These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16945550)

  • 1. Molecular markers in the diagnosis of prostate cancer.
    van der Poel HG
    Crit Rev Oncol Hematol; 2007 Feb; 61(2):104-39. PubMed ID: 16945550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene polymorphisms and prostate cancer: the evidence.
    Dianat SS; Margreiter M; Eckersberger E; Finkelstein J; Kuehas F; Herwig R; Ayati M; Lepor H; Djavan B
    BJU Int; 2009 Dec; 104(11):1560-72. PubMed ID: 20053187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular changes in prostatic cancer.
    Bott SR; Arya M; Shergill IS; Williamson M
    Surg Oncol; 2005 Aug; 14(2):91-104. PubMed ID: 15993579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens and the molecular epidemiology of prostate cancer.
    Chu LW; Reichardt JK; Hsing AW
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):261-70. PubMed ID: 18438175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autochthonous mouse models for prostate cancer: past, present and future.
    Huss WJ; Maddison LA; Greenberg NM
    Semin Cancer Biol; 2001 Jun; 11(3):245-60. PubMed ID: 11407949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of prostate cancer: clinical translational opportunities.
    Vecchione A; Gottardo F; Gomella LG; Wildemore B; Fassan Ms; Bragantini E; Pagano F; Baffa R
    J Exp Clin Cancer Res; 2007 Mar; 26(1):25-37. PubMed ID: 17550130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease: Polymorphisms of androgen regulatory genes in the development of prostate cancer.
    Singh AS; Chau CH; Price DK; Figg WD
    Nat Clin Pract Urol; 2005 Feb; 2(2):101-7. PubMed ID: 16474655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into prostate cancer biology.
    Balakumaran BS; Febbo PG
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):773-96. PubMed ID: 16861114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomolecular markers of outcome prediction in prostate cancer.
    Lopergolo A; Zaffaroni N
    Cancer; 2009 Jul; 115(13 Suppl):3058-67. PubMed ID: 19544547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling human prostate cancer in genetically engineered mice.
    Wang F
    Prog Mol Biol Transl Sci; 2011; 100():1-49. PubMed ID: 21377623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PC-1/PrLZ contributes to malignant progression in prostate cancer.
    Zhang H; Wang J; Pang B; Liang RX; Li S; Huang PT; Wang R; Chung LW; Zhau HE; Huang C; Zhou JG
    Cancer Res; 2007 Sep; 67(18):8906-13. PubMed ID: 17875733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular markers for prostate cancer.
    Reynolds MA; Kastury K; Groskopf J; Schalken JA; Rittenhouse H
    Cancer Lett; 2007 Apr; 249(1):5-13. PubMed ID: 17303324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
    Rouprêt M; Hupertan V; Yates DR; Catto JW; Rehman I; Meuth M; Ricci S; Lacave R; Cancel-Tassin G; de la Taille A; Rozet F; Cathelineau X; Vallancien G; Hamdy FC; Cussenot O
    Clin Cancer Res; 2007 Mar; 13(6):1720-5. PubMed ID: 17363525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.
    Huang SP; Yu CC; Liu CC; Wu TT; Huang CH; Wu MT
    Urol Int; 2008; 81(1):36-40. PubMed ID: 18645269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of reporter gene expression in prostate cancer: an overview.
    Singh A; Massoud TF; Deroose C; Gambhir SS
    Semin Nucl Med; 2008 Jan; 38(1):9-19. PubMed ID: 18096460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetics and molecular genetics of cancer of the prostate.
    Brothman AR
    Am J Med Genet; 2002 Oct; 115(3):150-6. PubMed ID: 12407695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer.
    Mononen N; Schleutker J
    J Urol; 2009 Apr; 181(4):1541-9. PubMed ID: 19230916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of prostate cancer progression to androgen independence.
    McPhaul MJ
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):373-88. PubMed ID: 18471793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
    Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
    Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.